Best practices for venture philanthropy collaborations between disease-focused foundations and for-profit life science companies by Joanne Chang.
Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2010. === Cataloged from PDF version of thesis. === Includes bibliographical references (p. 69-71). === The history of private philanthropy in the US has been dominated by family foundations with arms-length philanthropy practice...
Main Author: | |
---|---|
Other Authors: | |
Format: | Others |
Language: | English |
Published: |
Massachusetts Institute of Technology
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/1721.1/58400 |
id |
ndltd-MIT-oai-dspace.mit.edu-1721.1-58400 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-MIT-oai-dspace.mit.edu-1721.1-584002019-05-02T16:34:17Z Best practices for venture philanthropy collaborations between disease-focused foundations and for-profit life science companies by Joanne Chang. Chang, Joanne Fiona E. Murray and Chris Varma. Harvard University--MIT Division of Health Sciences and Technology. Harvard University--MIT Division of Health Sciences and Technology. Harvard University--MIT Division of Health Sciences and Technology. Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2010. Cataloged from PDF version of thesis. Includes bibliographical references (p. 69-71). The history of private philanthropy in the US has been dominated by family foundations with arms-length philanthropy practices that largely existed in separation from commercial enterprise and business operations. This paper looks at emerging organizational and funding models being used in a wide range of disease areas in which philanthropy has shifted towards a more "venture-oriented" model sometimes referred to as disease foundation venture philanthropy (DFVP) as practiced by disease focused foundations (DFFs). More specifically, this research seeks to understand how these models map onto the range of translational challenges confronted by those engaged in bringing ideas from the bench to the bedside and it explores our current understanding of DFVP best practices. It concludes by raising questions and addressing issues designed to assist those who seek to setup successful collaborations between DFFs and industry partners. S.M. 2010-09-03T18:36:02Z 2010-09-03T18:36:02Z 2010 2010 Thesis http://hdl.handle.net/1721.1/58400 656253175 eng M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 71 p. application/pdf Massachusetts Institute of Technology |
collection |
NDLTD |
language |
English |
format |
Others
|
sources |
NDLTD |
topic |
Harvard University--MIT Division of Health Sciences and Technology. |
spellingShingle |
Harvard University--MIT Division of Health Sciences and Technology. Chang, Joanne Best practices for venture philanthropy collaborations between disease-focused foundations and for-profit life science companies by Joanne Chang. |
description |
Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology, 2010. === Cataloged from PDF version of thesis. === Includes bibliographical references (p. 69-71). === The history of private philanthropy in the US has been dominated by family foundations with arms-length philanthropy practices that largely existed in separation from commercial enterprise and business operations. This paper looks at emerging organizational and funding models being used in a wide range of disease areas in which philanthropy has shifted towards a more "venture-oriented" model sometimes referred to as disease foundation venture philanthropy (DFVP) as practiced by disease focused foundations (DFFs). More specifically, this research seeks to understand how these models map onto the range of translational challenges confronted by those engaged in bringing ideas from the bench to the bedside and it explores our current understanding of DFVP best practices. It concludes by raising questions and addressing issues designed to assist those who seek to setup successful collaborations between DFFs and industry partners. === S.M. |
author2 |
Fiona E. Murray and Chris Varma. |
author_facet |
Fiona E. Murray and Chris Varma. Chang, Joanne |
author |
Chang, Joanne |
author_sort |
Chang, Joanne |
title |
Best practices for venture philanthropy collaborations between disease-focused foundations and for-profit life science companies by Joanne Chang. |
title_short |
Best practices for venture philanthropy collaborations between disease-focused foundations and for-profit life science companies by Joanne Chang. |
title_full |
Best practices for venture philanthropy collaborations between disease-focused foundations and for-profit life science companies by Joanne Chang. |
title_fullStr |
Best practices for venture philanthropy collaborations between disease-focused foundations and for-profit life science companies by Joanne Chang. |
title_full_unstemmed |
Best practices for venture philanthropy collaborations between disease-focused foundations and for-profit life science companies by Joanne Chang. |
title_sort |
best practices for venture philanthropy collaborations between disease-focused foundations and for-profit life science companies by joanne chang. |
publisher |
Massachusetts Institute of Technology |
publishDate |
2010 |
url |
http://hdl.handle.net/1721.1/58400 |
work_keys_str_mv |
AT changjoanne bestpracticesforventurephilanthropycollaborationsbetweendiseasefocusedfoundationsandforprofitlifesciencecompaniesbyjoannechang |
_version_ |
1719043075779592192 |